Please provide your email address to receive an email when new articles are posted on . Epstein-Barr virus activates certain B cells involved in systemic lupus erythematosus disease pathogenesis. The ...
Rituximab is a chimeric mouse–human monoclonal antibody (mAb) that targets the B-cell surface marker CD20 with high affinity. CD20 expression spans the developmental stages from the pre-B cell until ...
Systemic lupus erythematosus (SLE) involves ongoing inflammation, tissue damage from immune complexes, and incomplete immune resolution. A key factor ...
Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to diagnose and evaluate people with systemic lupus erythematosus (SLE). The ...
Objective Methylprednisolone pulses (MP) help achieve prolonged remission in patients with moderate–severe systemic lupus ...
Objective To investigate the relationship between adverse childhood experiences (ACEs) and health outcomes in childhood-onset ...
Dr. Hui-Chen Hsu is Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology. Dr. Hsu collaborated with Drs. John D. Mountz, Hao Li, Jun Li, Yong Zhou, David Crossman, ...
Please provide your email address to receive an email when new articles are posted on . Nipocalimab is a potentially steroid sparing, immunoselective treatment designed to block FcRn and target IgG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results